The
potentially dilutive common shares that were excluded from the calculation of diluted net loss per share because their effect would have
been antidilutive are as follows. Share amounts for the periods ended June 30, 2024, have been adjusted retroactively for the Reverse
Stock Split.
Schedule of Dilutive Common Shares were Excluded from Calculation of Diluted
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 30, |
|
|
June 30, |
|
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
Shares subject to options to purchase common stock |
|
|
675,779 |
|
|
|
730,649 |
|
|
|
675,779 |
|
|
|
730,649 |
|
Unvested restricted stock units |
|
|
— |
|
|
|
61,108 |
|
|
|
— |
|
|
|
61,108 |
|
Shares subject to warrants to purchase common stock |
|
|
900,000 |
|
|
|
350,001 |
|
|
|
900,000 |
|
|
|
350,001 |
|
Total |
|
|
1,575,779 |
|
|
|
1,141,758 |
|
|
|
1,575,779 |
|
|
|
1,141,758 |
|
|